Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis.

Bai L, Lennon DP, Eaton V, Maier K, Caplan AI, Miller SD, Miller RH.

Glia. 2009 Aug 15;57(11):1192-203. doi: 10.1002/glia.20841.

2.

Adipose-derived mesenchymal stem cells modulate the immune response in chronic experimental autoimmune encephalomyelitis model.

Shalaby SM, Sabbah NA, Saber T, Abdel Hamid RA.

IUBMB Life. 2016 Feb;68(2):106-15. doi: 10.1002/iub.1469. Epub 2016 Jan 12. Review.

3.

Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.

Rostami A, Ciric B.

J Neurol Sci. 2013 Oct 15;333(1-2):76-87. doi: 10.1016/j.jns.2013.03.002. Epub 2013 Apr 8. Review.

4.
5.

Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosis.

Darlington PJ, Boivin MN, Bar-Or A.

Expert Rev Neurother. 2011 Sep;11(9):1295-303. doi: 10.1586/ern.11.113. Review.

6.

Role of Th1 and Th2 cells in autoimmune demyelinating disease.

Nagelkerken L.

Braz J Med Biol Res. 1998 Jan;31(1):55-60. Review.

PMID:
9686179
7.

Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis.

Gharibi T, Ahmadi M, Seyfizadeh N, Jadidi-Niaragh F, Yousefi M.

Cell Immunol. 2015 Feb;293(2):113-21. doi: 10.1016/j.cellimm.2015.01.002. Epub 2015 Jan 10. Review.

PMID:
25596473
8.

Mesenchymal stem cell transplantation in multiple sclerosis.

Cohen JA.

J Neurol Sci. 2013 Oct 15;333(1-2):43-9. doi: 10.1016/j.jns.2012.12.009. Epub 2013 Jan 4. Review.

9.

Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis.

Xiao J, Yang R, Biswas S, Qin X, Zhang M, Deng W.

Int J Mol Sci. 2015 Apr 24;16(5):9283-302. doi: 10.3390/ijms16059283. Review.

10.

Growth factors and myelin regeneration in multiple sclerosis.

Webster HD.

Mult Scler. 1997 Apr;3(2):113-20. Review.

PMID:
9291164
11.

The influence of sex hormones on cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis: a review.

van den Broek HH, Damoiseaux JG, De Baets MH, Hupperts RM.

Mult Scler. 2005 Jun;11(3):349-59. Review.

PMID:
15957520
12.

Multiple Sclerosis and Obesity: Possible Roles of Adipokines.

Guerrero-García JJ, Carrera-Quintanar L, López-Roa RI, Márquez-Aguirre AL, Rojas-Mayorquín AE, Ortuño-Sahagún D.

Mediators Inflamm. 2016;2016:4036232. Epub 2016 Sep 18. Review.

13.

The meninges: new therapeutic targets for multiple sclerosis.

Russi AE, Brown MA.

Transl Res. 2015 Feb;165(2):255-69. doi: 10.1016/j.trsl.2014.08.005. Epub 2014 Sep 1. Review.

14.
15.

The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.

Auletta JJ, Bartholomew AM, Maziarz RT, Deans RJ, Miller RH, Lazarus HM, Cohen JA.

Immunotherapy. 2012 May;4(5):529-47. doi: 10.2217/imt.12.41. Review.

16.

How and why do T cells and their derived cytokines affect the injured and healthy brain?

Filiano AJ, Gadani SP, Kipnis J.

Nat Rev Neurosci. 2017 Jun;18(6):375-384. doi: 10.1038/nrn.2017.39. Epub 2017 Apr 27. Review.

PMID:
28446786
17.

Data against a Common Assumption: Xenogeneic Mouse Models Can Be Used to Assay Suppression of Immunity by Human MSCs.

Prockop DJ, Oh JY, Lee RH.

Mol Ther. 2017 Aug 2;25(8):1748-1756. doi: 10.1016/j.ymthe.2017.06.004. Epub 2017 Jun 22. Review.

PMID:
28647464

Supplemental Content

Support Center